Recommendations say that a broader group of women should be considered for BRCA mutation testing, and the U.S. Food and Drug Administration issues a proposal to require that cigarettes come with graphic warnings.

by Kate Yandell

Minister and thyroid cancer survivor Thurselle C. Williams speaks at conferences and events about cancer awareness and, ultimately, healing following her 2016 diagnosis.

by Erin L. Boyle

A radiation oncologist draws on her personal experience as she researches financial toxicity, and the U.S. Food and Drug Administration issues a third tissue-agnostic approval.

by Kate Yandell

A liquid biopsy test is effective in detecting a cancer biomarker, Medicare opts to cover CAR-T cell therapies, and an e-cigarette maker spends millions to defeat a ban on sales in San Francisco.

by Kevin McLaughlin

The U.S. Food and Drug Administration for the first time approves an immune checkpoint inhibitor for treatment of esophageal cancer, and a two-drug combination shows promise for treating chronic lymphocytic leukemia.

by Kate Yandell

A survey finds many patients prefer talking through imaging findings related to cancer with their physician rather than viewing reports online—but only if the wait for results is short.

by Cindy Kuzma

The U.S. Food and Drug Administration requests a recall of textured breast implants, and a study indicates BRCA2 mutations are associated with non-Hodgkin lymphoma.

by Kate Yandell

A study sheds light on the effects of hurricanes on cancer patients receiving radiation therapy, and the Biden Cancer Initiative suspends operations.

by Kate Yandell and Bradley Jones

Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.

by Emma Yasinski

Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.

by Ashley P. Taylor